First it was open access, then pure and simple pirating (Sci-Hub), and now preprints, as this recent New York Times article outlines. The business model of the major scientific publishers is under attack.
This probably doesn’t come as a surprise to many of us. For one, it’s been a slow and steady process occurring over the course of many years. Secondly, it’s something that scientists have openly complained about for a long while. The system of publishing in the biomedical sciences is slow, arduous, and by and large hasn’t been improved upon in centuries. The cost to institutions of obtaining subscriptions is huge.
That said, many of the large scientific publishers are some of the most entrenched, disruption-shielded companies in all of the sciences. Not only have they had a near-monopoly on the mass dissemination of scientific information for centuries, they have also been the de facto method by which scientists are evaluated. For any academic and many industry scientists, how many articles you publish and in what journals has the power to define the course – and the fruitfulness – of your career. Almost all generally accepted methods for measuring the impact of a scientist’s contributions are based around citations from publications in scientific journals. Deviating from the system would be a massive professional risk for all but the most respected and recognized scientists.
With such massive forces reinforcing the system of scientific publishing, escaping it would seem intractable. Now, perhaps for the first time, it seems vulnerable.
Understanding the Points of Weakness
The scientific publishing industry is something of a dinosaur, built for a world in which information had to be transmitted through the dissemination of physical objects. While it adapted rapidly to digital distribution in the internet age, it failed to accommodate for a number of other changing realities which altered its value to scientists.
Primarily, scientists no longer had an inherent need for publishers in order to effectively disseminate information. While publishers still helped organize and prioritize information, the dissemination of information has become easy, near-immediate, and free. This both decreased the value of publishers and also decreased barriers to pirating, since the unit-cost of disseminating any given article (or a great many articles) is effectively zero. Sci-Hub may be an unsolvable problem for publishers, and it’s not the only one of its kind. Scientists who don’t want to partake in such blatant piracy can use the #icanhazpdf hashtag on Twitter and have an article sent to them by a peer with access. This leads to a downwards spiral effect on the value that publishers add from an information dissemination standpoint – easier access to information leads to more pirating, which in turn provides easier access to information, all the while making publishers roles less as couriers and more as gatekeepers, trying to ensure that information can only be seen by those who pay for the privilege.
Additionally, while digital technologies were being used to make many aspects of life easier and faster, and scientific technologies continued to evolve at a rapid pace, innovations in publishing were extremely limited. Aside from eliminating the need to physically mail manuscripts, the arduous peer review process remains largely unchanged. While there is no immediately obvious replacement for peer review, the overall experience of submitting articles for publication remained very slow in a world that was becoming very fast, making the perception of the process feel slower even though it was no slower than before. This increasingly negative perception also erodes value, as it makes the traditional publishing process seem more flawed.
Costs, however, have not been reduced. Each publisher has, in essence, a monopoly on the information which they own. They do not compete to provide access to any given journal or article, so there is relatively little competitive pressure to decrease prices, aside from the constraints of institutional libraries’ limited budgets. Therefore the present situation is really not at all surprising. The perception of value has decreased – perhaps significantly so – yet prices have not decreased to match. The market believes it is overpaying, and it is revolting against the industry in a search for both a better value, a better experience, and a structure which is more in line with scientists’ own values.

Important Lessons for All Industries
Nothing exists in a vacuum. It was easy for scientific publishers to get comfortable with their seemingly irreplaceable status as the couriers of knowledge, but as the would changed around them they shifted from facilitating the spread of knowledge to inhibiting it. However, big publishers still have yet to substantially alter their business models to adjust to a very different reality. We must learn from this.
- Get what you give. Just because the products or services which you are providing remain unchanged, that doesn’t mean that your value remains unchanged as well. Benefits are relative, and your pricing should adapt to the benefits provided – even if you’re massively entrenched.
- Fighting your customers’ values is a losing battle. Scientists largely believe in sharing information. Once technology evolved to allow instant sharing of information at any scale, publishers became inhibitors to the flow of information. Not only were they inhibitors, but they were profiting from limiting access to knowledge. This made them a big target for scientists’ discontent.
- Customer experience always matters. Even if there are no alternatives, consistently poor customer experience will drive customers to seek alternatives. It creates an environment which is ripe for disruption.
- Anyone can be unseated, no matter how entrenched. The traditional scientific publishers haven’t been dug out yet, and they still have some time to adapt, but they are in desperate need of business model innovation. If they cannot adapt their business model, they will eventually fail.
No company, no matter how large it is, how much market share it has, how long and storied its history, or how entrenched it has become, is invulnerable. Eventually, everyone must adapt. It has become increasingly clear that one of the pillars of maintaining a successful company in today’s dynamic environments is agility. Time will tell whether publishers have the necessary agility to survive.
The average product launch has a lot in common with a firework show. A lot of effort goes into it and it’s relatively expensive. It makes a big splash and does a fairly good job of getting a lot of attention. Also like a firework show, after the big launch effort is over, the audience goes about their lives as if it never happened. People won’t think about it much after it’s over, and within a few weeks it’s lost to history.
Most life science companies still have a product focus, and many can get away with it because our industry, along with many other B2B industries, is a bit behind the marketing curve. Many companies place a very high priority on operational efficiency and building better products. Those things are undeniably important, but in many circumstances they’re not sufficient for winning markets anymore. There are plenty of products which were incremental improvements, or even significant improvements, and were offered at equal or lower products than their mainstream competitors but still failed. While there are many ways to fail in marketing a product, one of the largest is marketing a product. (Yes, you read that correctly.)
“But our product performs better than the competitors! And it performs better for almost all applications!”
For most of you reading this, your company will have a LinkedIn profile. It doesn’t require much – upload your logo, post some basic company info, and copy-paste a paragraph or two from the “about” page of your website and you’re just about set. We looked at 408 life science tools and services companies and found that 69 did not have LinkedIn profiles – that’s only 17%. So why bring it up?
A lot of focus goes into optimizing marketing activities. That focus is important and very helpful in numerous ways, but all the A/B testing and conversion optimization in the world gets flushed down the drain as soon as a customer actually contacts your company. Not nearly as much effort goes into improving customer contacts. Perhaps this is because person-to-person interaction inherently has some degree of variability, or because sales and support staff are expected to be highly competent at customer interactions, or because people don’t realize that customer interactions can be optimized. Regardless of the reason, life science companies need to realize that customer communications can be improved, and there are a number of definite (and often relatively easy) ways to do so. We discuss some below.